(Q37383474)

English

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

multicenter clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Judith Bellmann-Strobl

7

object named as

Judith Bellmann-Strobl

0 references

object named as

Nasrin Asgari

13

0 references

8

object named as

Sven Jarius

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Friedemann Paul

20

object named as

Friedemann Paul

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Brigitte Wildemann

9

object named as

Brigitte Wildemann

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

author name string

Florence Pache

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Hanna Zimmermann

2

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Janine Mikolajczak

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Sophie Schumacher

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Anna Lacheta

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Frederike C Oertel

6

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Amy Waldman

11

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Kerstin Soelberg

12

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Marius Ringelstein

14

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Orhan Aktas

15

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Nikolai Gross

16

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Mathias Buttmann

17

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Thomas Ach

18

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Klemens Ruprecht

19

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Alexander U Brandt

21

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

in cooperation with the Neuromyelitis Optica Study Group (NEMOS)

22

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 November 2016

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Journal of Neuroinflammation

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

13

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

282

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

describes a project that uses

object named as

ggplot

1 reference

CZ Software Mentions: A large dataset of software mentions in the biomedical literature

0 references

https://scigraph.springernature.com/pub.10.1186/s12974-016-0720-6

0 references

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

Fulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

Reliability of Intra-Retinal Layer Thickness Estimates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

Histopathology and clinical course of MOG-antibody-associated encephalomyelitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor α1 subunit in patients with isolated optic neuritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

Neuromyelitis optica: clinical features, immunopathogenesis and treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

Optic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

The spectrum of MOG autoantibody-associated demyelinating diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

In vivo identification of morphologic retinal abnormalities in neuromyelitis optica

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

The OSCAR-IB consensus criteria for retinal OCT quality assessment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

Proper method for calculating average visual acuity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

9 September 2017

Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

14 September 2017

Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

2 September 2018

Pattern reversal evoked potentials: gender differences and age-related changes in amplitude and latency.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

2 September 2018

MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study: Table 1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5088645

3 December 2018

Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica

1 reference

https://pubmed.ncbi.nlm.nih.gov/27802824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Collateral benefit: the comeback of MOG antibodies as a biomarker in neurological practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/27802824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/27802824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S12974-016-0720-6

0 references

Dimensions Publication ID

0 references

release_evklcyxsozbd7naji3fcgdgoem

1 reference

https://api.fatcat.wiki/v0/release/evklcyxsozbd7naji3fcgdgoem

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37383474&oldid=1841575799"